Antibacterial drugs and cyclodextrin inclusion complexes: a patent review
The patents analyzed in the review used treatments based on antibiotics already on the market, natural products, and synthesized molecules
A forum for researchers, students and applicants in the field of cyclodextrin technology
The patents analyzed in the review used treatments based on antibiotics already on the market, natural products, and synthesized molecules
Cyclodextrin metal-organic frameworks (CD-MOF) are a class of biocompatible MOFs with a great potential in drug delivery applications. Original CD-MOF
This review article summarises over 200 reports published by the end of 2021 that discuss the complexation of CDs with
This review covers the following topics: Methods for preparing CD-based films Blending and incorporation of other materials with CDs for
Sulfobutyl ether derivative of β-cyclodextrin, cross-linked in the presence of antibacterial drug moxifloxacin, forms water-soluble polymeric nanoparticles (50–150 nm in diameter),
Gram-negative bacteria possess numerous defenses against antibiotics, due to the intrinsic permeability barrier of their outer membrane, explaining the recalcitrance
Novel multifunctional drug delivery systems were developed by the Sortino’s group [1]. βCD-NBFNO1 and βCD-NBFNO2, covalently integrating an N-nitroso amino-nitro-benzofurazan
2-Phenyl ethanol is a natural compound, which have many applications due to its nice fragrance, bacteriostatic and antifungal character. It
A recent paper in Cell Reports published an interesting finding: polymeric degradation products (compound X and Z, respectively) of antibiotics
Polylactic acid (PLLA) was internally blended with zinc oxide nanoparticles and chitosan and carboxyethyl BCD (CEBCD) layers were deposited by